Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 26.03.2024       ParTec AG

First Berlin Equity Research on 26/03/2024 initiated coverage on ParTec AG (ISIN: DE000A3E5A34/ Bloomberg: JY0 GR). Analyst Simon Scholes placed a BUY rating on the stock, with a EUR 220.00 price target. Abstract: Partec has designed, patented and brought to market a new type of supercomputer, which for a given initial financial outlay, perform [ … ]
Tue, 26.03.2024       M1 Kliniken AG

First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 13,20 auf EUR 18,00. Zusammenfassung: Wir bekräftigen unsere Kaufempfehlung für die M1 Kliniken AG (M1) und erhöhen unser Ku [ … ]
Mon, 25.03.2024       PSI AG

First Berlin Equity Research has published a research update on PSI SE (ISIN: DE000A0Z1JH9). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 30.00 price target. Abstract: PSI has published preliminary key figures for 2023. Sales climbed 8.9% to €269.9m (2022: €247.9m) while EBIT fell to €5.6m (2022: €2 [ … ]
Wed, 20.03.2024       Media and Games Invest SE

First Berlin Equity Research hat ein Research Update zu Media and Games Invest SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,60. Zusammenfassung: MGI meldete für den Monat Februar einen Rekordumsatz, der durch ein organisches Umsatzwachstum ( [ … ]
Mon, 18.03.2024       Deutsche Rohstoff AG

First Berlin Equity Research has published a research update on Deutsche Rohstoff AG (ISIN: DE000A0XYG76). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 47.00 to EUR 46.00. Abstract: 2023 sales of €196.5m and EBITDA of €158.2m both came in towards the top end of guidance. Meanwhile, 2023 produ [ … ]
Mon, 18.03.2024       Grand City Properties S.A.

First Berlin Equity Research hat ein Research Update zu Grand City Properties S.A. (ISIN: LU0775917882) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 12,60 auf EUR 12,50. Zusammenfassung: Das Nettomietwachstum auf vergleichbarer Basis (LFL) von 3,3% führte zu einer guten operat [ … ]
Mon, 11.03.2024       Media and Games Invest SE

First Berlin Equity Research hat ein Research Update zu Media and Games Invest SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 3,20 auf EUR 3,60. Zusammenfassung: MGI überraschte im vierten Quartal mit einer Umsatzsteigerung, die durch ein starkes J/ [ … ]
Mon, 04.03.2024       European Lithium Limited

First Berlin Equity Research has published a research update on European Lithium Limited (ISIN: AU000000EUR7). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 0.17 price target. Abstract: Pricing for lithium chemicals quadrupled during 2021/22 as worldwide sales of EVs tripled. Since early 2023 prices have collapsed by ca [ … ]
Tue, 27.02.2024       Valneva

First Berlin Equity Research has published a research update on Valneva SE (ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 8.90 to EUR 8.60. Abstract: FY/23 product revenues recovered strongly (+26% to €144.6m) in line with resurgent travel activity. The current cash position is [ … ]
Tue, 27.02.2024       Cardiol Therapeutics Inc

First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera reiterated his BUY rating and maintained his USD 3.60 price target. Abstract: Cardiol Therapeutics (Cardiol) announced that the FDA has granted Orphan Drug Designation (ODD) in the US for its lead drug candid [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 21.11.2024, Calendar Week 47, 326th day of the year, 40 days remaining until EoY.